The purpose of this study is to determine the effect of a systemic infusion of angiotensin II
on haemodynamics and urine output in critically ill patients with severe sepsis/septic shock
and acute renal failure.
It will also help determine the feasibility of conducting a definitive and adequately powered
randomised controlled trial of angiotensin II in such patients that would assess mortality
and need for renal replacement therapy as endpoints.
Phase:
Phase 2
Details
Lead Sponsor:
Austin Health
Collaborators:
Northern Health and Social Care Trust Western Hospital, Australia